Format

Send to

Choose Destination
See comment in PubMed Commons below
Tob Control. 2008 Jun;17(3):177-82. doi: 10.1136/tc.2007.022368. Epub 2008 Feb 19.

A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand.

Author information

1
Department of Pharmacy Practice, Naresuan University, Phitsanulok 65000, Thailand.

Abstract

OBJECTIVE:

To estimate the incremental cost-effectiveness ratio of a structured community pharmacist-based smoking cessation programme compared with usual care.

DESIGN:

A cost-effectiveness study using a healthcare system perspective Population: Two simulated cohorts of smokers: male and female aged 40, 50 and 60 years who regularly smoke 10-20 cigarettes per day. Intervention and comparator: A structured community pharmacist-based smoking cessation (CPSC) programme compared to usual care.

MAIN OUTCOME MEASURE:

Cost per life year gained (LYG) attributable to the smoking cessation programme.

RESULTS:

The CPSC programme results in cost savings of 17,503.53 baht ( pound250; euro325; $500) to the health system and life year gains of 0.18 years for men and; costs savings of 21,499.75 baht ( pound307; euro399; $614) and life year gains of 0.24 years for women. A series of sensitivity analyses demonstrate that both cost savings and life year gains are sensitive to variations in the discount rate and the long-term smoking quit rate associated with the intervention.

CONCLUSION:

From the perspective of the health system, the CPSC programme yields cost savings and life year gains. This finding provides important information for health policy decision-makers when determining the magnitude of resources to be allocated to smoking cessation service in community pharmacy.

PMID:
18285385
DOI:
10.1136/tc.2007.022368
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center